PASG FY 2021 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$29M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$186M

Net Income

-$185M

EPS (Diluted)

$-69.51

Cash Flow

Operating Cash Flow

-$127M

Free Cash Flow

-$153M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$355M

Total Liabilities

$36M

Stockholders' Equity

$319M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$186M	-$113M	-64.5%
Net Income	-$185M	-$112M	-65.2%